Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2006
10/24/2006US7125687 Presenilin enhancers assays
10/24/2006US7125686 Proteins and methods for producing the proteins
10/24/2006US7125684 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER)
10/24/2006US7125679 Methods to screen peptide libraries using minicell display
10/24/2006US7125676 Modified human sodium channel type 1 alpha subunit (SCN1A) nucleic acid that encodes an SCN1A voltage-gated sodium channel polypeptide that regulates Na+ ion membrane permeation; identifying a sodium channel modulator
10/24/2006US7125675 Method for inhibiting tumor invasion or spreading in a subject
10/24/2006US7125673 Preparing DNA from paraffin-embedded, formalin-fixed tissue samples for promoter methylation analysis by deparaffinizing the samples; boiling them in citrate buffer; and extracting DNA from them; hypermethylation of ATM gene promoter correlates with decreased overall head & neck cancer survival
10/24/2006US7125672 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
10/24/2006US7125670 Comprises activated CD4 T-cells (ACT-4-L) ligand polypeptide for detection of immunomodulators; autoimmune diseases; drug screening; immunosuppressants; viricides
10/24/2006US7125666 A nucleic acid encodes the polypeptide or fragment has ability to form a triple helix, form higher order collagen fibrils or fibers and provide tensile strenght or flexibility to muscle connective tissue, recognized by R34 antibody
10/24/2006US7125662 Identifying microorganismal nucleotide sequences associated with antibiotic resistance protein for use as components to improve identification of vector transformed cells
10/24/2006US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein
10/24/2006US7125556 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin
10/24/2006US7125554 Engineered superantigen for human therapy
10/24/2006US7125549 Synergistic combination of two adenoviral vectors that are replication incompetent cotranscomplements of each other and one is recombinant 1014; enhances both gene delivery and gene expression of genetic sequences contained within the vector.
10/24/2006US7125548 Nucleotide sequences coding microorganismal cistron; for use in detection of microoganismal infection
10/24/2006CA2342948C Attenuated vaccine for blastomyces dermatitidis
10/24/2006CA2211165C Methods for sensitive detection of reverse transcriptase
10/24/2006CA2121545C Method for transforming monocotyledons
10/24/2006CA2104508C Improved method for nucleic acid amplification
10/21/2006CA2541986A1 Carbonic anhydrase having increased stability under high temperatue conditions
10/19/2006WO2006110915A2 Vaccine formulations for leishmania
10/19/2006WO2006110852A1 System for producing synthetic promoters
10/19/2006WO2006110813A2 Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases
10/19/2006WO2006110689A2 Method of increasing the function of an aav vector
10/19/2006WO2006110688A2 Rnai therapeutic for respiratory virus infection
10/19/2006WO2006110680A1 Rapid generation of long synthetic centromeric tandem repeats for mammalian artificial chromosome formation
10/19/2006WO2006110677A2 Gene inactivated mutants with altered protein production
10/19/2006WO2006110607A2 Methods for treating infectious disease exacerbated asthma
10/19/2006WO2006110594A2 Sema4d in cancer diagnosis, detection and treatment
10/19/2006WO2006110508A2 Plants with increased phosphorous uptake
10/19/2006WO2006110506A2 Root-specific phoshate transporter promoters
10/19/2006WO2006110413A2 Haemophilus influenzae type b
10/19/2006WO2006110240A2 Gene transfer with adenoviruses having modified fiber proteins
10/19/2006WO2006110188A2 Genes conferring herbicide resistance
10/19/2006WO2006110083A1 A host cell comprising a vector for production of proteins requiring gamma-carboxylation
10/19/2006WO2006109855A1 Peptide having food intake stimulating effect and method for screening for the peptide
10/19/2006WO2006109781A1 Process for production of glycoprotein composition
10/19/2006WO2006109751A1 Method for producing protein by cell-free protein synthesis system
10/19/2006WO2006109698A1 Composition comprising genetically engineered erythropoietin
10/19/2006WO2006109696A1 Composition comprising genetically engineered follicle-stimulating hormone
10/19/2006WO2006109695A1 Composition comprising genetically engineered haptoglobin
10/19/2006WO2006109632A1 NOVEL α-KETO ACID TRANSFERASE, GENE FOR THE SAME, AND USE OF THE SAME
10/19/2006WO2006109619A1 5-fluorouracil-resistant bacteria and method for production thereof
10/19/2006WO2006109592A1 Antibody substituting for function of blood coagulation factor viii
10/19/2006WO2006109588A1 Novel microalgae and process for producing hydrocarbon
10/19/2006WO2006109578A1 Altered pyrroloquinoline-quinone-dependent glucose dehydrogenase and method of improving substrate specificity of pyrroloquinoline-quinone-dependent glucose dehydrogenase
10/19/2006WO2006109535A1 Dna sequence analyzer and method and program for analyzing dna sequence
10/19/2006WO2006109533A1 Method for production of antibody directed against cell membrane surface antigen epitope and assaying method
10/19/2006WO2006109479A1 Gene expression cassette and transformant, and process for production of 2-deoxy-scyllo-inosose and process for purification of 2-deoxy-scyllo-inosose using the transformant
10/19/2006WO2006109424A1 Dnas encoding protein having function of forming and regulating cellulosic fiber cell wall in tree trunk and promoter dnas of the same
10/19/2006WO2006109420A1 Method of examining plant qualities and species
10/19/2006WO2006109303A2 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them
10/19/2006WO2006109301A2 Molecules and methods of using same for treating mcp-1/ccr2 associated diseases
10/19/2006WO2006109192A2 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith
10/19/2006WO2006109174A2 Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid
10/19/2006WO2006109092A1 Conjugate comprising p21 protein for the treatment of cancer
10/19/2006WO2006109045A2 Cathepsin s antibody
10/19/2006WO2006108830A2 TRANSPLASTOMIC PLANTS EXPRESSING α 1-ANTITRYPSIN
10/19/2006WO2006108826A1 Basic protein purification tags from thermophilic bacteria
10/19/2006WO2006108718A1 Micro rna
10/19/2006WO2006108702A1 High-phosphate starch
10/19/2006WO2006108674A2 Elite event a2704-12 and methods and kits for identifying such event in biological samples
10/19/2006WO2006108599A2 Ghrelin binding nucleic acids
10/19/2006WO2006108590A1 Modified coagulation factor viii with enhanced stability and its derivates
10/19/2006WO2006108525A1 Reconstructed human mariner transposon capable of stable gene transfer into chromosomes in vertebrates
10/19/2006WO2006108474A2 Use of a galectin-1-trageted rnai-based approach for the treatment of cancer
10/19/2006WO2006108473A1 Method for the determination of cellular transcriptional regulation by micro rnas
10/19/2006WO2006108273A1 Identification of a beta-1,3-n-acetylgalactosaminyltransferase (cgte) from campylobacter jejuni lio87
10/19/2006WO2006108226A1 Vaccine delivery system
10/19/2006WO2006108201A1 Promoter for the expression of foreign genes in neuronal cells
10/19/2006WO2006091824A3 Peptides for detection of antibody to porcine reproductive respiratory syndrome virus
10/19/2006WO2006085987A9 Rna interference in respiratory epitheial cells
10/19/2006WO2006082398A3 Nucleic acid constructs
10/19/2006WO2006078273A3 Methods and compositions for producing recombinant proteins
10/19/2006WO2006071691A8 Rnai inhibition of serum amyloid a for treatment of glaucoma
10/19/2006WO2006068170A9 Method for improvement of heat stability of glucose dehydrogenase
10/19/2006WO2006066078A3 Fcϝriib-specific antibodies and methods of use thereof
10/19/2006WO2006065975B1 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor
10/19/2006WO2006065139A3 Deacylation of lps in gram negative bacteria
10/19/2006WO2006065126A3 Terpene hydroxylation
10/19/2006WO2006062398A3 Methods for the production and secretion of modified peptides
10/19/2006WO2006041910A3 Stem cells derived from uniparental embryos and methods of use thereof
10/19/2006WO2006040313A3 Mutant expandases
10/19/2006WO2006037081A3 Nanoparticle radiosensitizers
10/19/2006WO2006033689A8 Aav mediated gene delivery to cochlear cells
10/19/2006WO2006024291A3 Root-specific and xylem parenchyma-specific promoter
10/19/2006WO2006023869A3 Adenylate translocator protein gene non-coding regulatory elements for use in plants
10/19/2006WO2006023593A3 Malarial animal model having a chimeric human liver
10/19/2006WO2006017856A9 Methods for constructing antibiotic resistance free vaccines
10/19/2006WO2005097179A3 Stabilised tat antigen and the use thereof for anti-hiv vaccination
10/19/2006WO2005094569A8 Ion channel
10/19/2006WO2005092924A8 Rab9a, rab11a, and modulators thereof related to infectious disease
10/19/2006WO2005089252A3 Methods and compositions for the treatment of obesity
10/19/2006WO2005079342A3 Methods for coupling resistance alleles in tomato
10/19/2006WO2005070088A3 Chimeric sequences for tissue-specific gene expression in plants
10/19/2006WO2005049846A9 Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer
10/19/2006WO2005016132A3 Diagnostics for sars virus
10/19/2006WO2004084810A3 Novel imidazoline receptor homologs
10/19/2006WO2004076638A3 Polynucleotides and polypeptides in plants